Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Johnson & Johnson Pharmaceutical Research & Development, L.L.C. (JJPRD) was the pharmaceutical R&D subsidiary of Johnson & Johnson, subsequently rebranded and integrated into Janssen Research & Development. As a predecessor entity, it conducted foundational early clinical research into esketamine that led to the development of Spravato for treatment-resistant depression.